Mon, January 10, 2022
Sun, January 9, 2022
Fri, January 7, 2022
Thu, January 6, 2022
Wed, January 5, 2022
Tue, January 4, 2022
Mon, January 3, 2022

Matthew Harrison Downgraded (BOLT) to Hold and Decreased Target to $11 on, Jan 6th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-11-on-jan-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Downgraded "Bolt Biotherapeutics, Inc." (BOLT) to Hold and Decreased Target from $45 to $11 on, Jan 6th, 2022.

Matthew has made no other calls on BOLT in the last 4 months.



There is 1 other peer that has a rating on BOLT. Out of the 1 peers that are also analyzing BOLT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Daina Graybosch of "SVB Leerink" Maintained at Buy with Decreased Target to $33 on, Wednesday, November 10th, 2021

Publication Contributing Sources